We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sarah McLaughlin MD, FSSO

Sarah A. McLaughlin MD, FSSO

Professor of Surgery, Chair, Department of Surgery, Mayo Clinic, Jacksonville, FL

Sarah A. McLaughlin, MD, is chair of the Department of Surgery and a consultant in the Division of Surgical Oncology at Mayo Clinic in Florida, with a joint appointment as a consultant in Quantitative Health Sciences.

Dr. McLaughlin is enterprise co-deputy director, Disease Groups, in Mayo Clinic Comprehensive Cancer Center, and she is a member of the Mayo Clinic Board of Trustees. She joined the staff of Mayo Clinic in 2007 and holds the academic rank of professor of surgery, Mayo Clinic College of Medicine and Science.

Dr. McLaughlin attended the University of Missouri where she earned her medical degree with distinction. She completed her internship and residency in general surgery at Mayo Clinic, and as a Mayo Clinic Scholar, she completed a breast surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center.

As a surgeon, Dr. McLaughlin treats patients with breast cancer, breast health concerns and lymphedema, with a focus on survivorship after breast cancer treatment. She served as medical director of the Robert and Monica Jacoby Center for Breast Health from 2016 to 2021 where she helped develop an improved access process for breast cancer patients. In addition, she championed a cross-training interdisciplinary care model for providers. She has been integral in developing the integrated model of breast care on the Florida campus.

Dr. McLaughlin’s research is focused on breast cancer, high-risk features of cancer, lymphedema etiology and prediction methods. She is frequently invited to give presentation on her work, and she has achieved over 100 publications in numerous peer-reviewed journals. She serves as a section editor of Annals of Surgical Oncology and helped develop the International Consortium Health Outcome Measures for breast cancer.